Top Story

NICE recommends Ixekizumab for severe plaque psoriasis in adults

SMC also published guidance on use of ixekizumab by the NHS in Scotland earlier this month.

Read more

Drug demonstrated statistically-significant improvements in progression-free survival over chemother...

Read more

CDMO supplies serialised products in markets including Turkey, Korea and China....

Read more

NASH is a major cause of liver disease worldwide...

Read more

Data show that a bleeding episode occurs every three to fifteen seconds worldwide....

Read more

Pfizer will fund the research at HitGen to discover unique small-molecule leads....

Read more

Findings consistent with results from phase III HAVEN 1 study in adults and adolescents....

Read more

BMS will receive a combined $470m upfront....

Read more

Ms Cafferkey will return to raise funds for children orphaned by the epidemic....

Read more

Fund is aimed at the 12 diseases identified by the UK Vaccine Network as a priority....

Read more

Organisations will explore drug discovery initiatives....

Read more